We are a well established innovative reasearch base Pharmaceutical Bulk drugs manufacturing company in the industrial city of India, Ankleshwar (Gujarat), with
an excellant multipurpose facility meeting GMP standards, manufacturing Bulk Drugs like
BULK DRUGS [A.P.I]
AMLODIPINE BESILATE [BP/EP] & MALEATE AMLODIPINE BESILATE [BP/EP]
GLIBENCLAMIDE [BP/EP/IP/USP] GLIBENCLAMIDE [GLYBURIDE]  [BP/EP/IP/USP]
NICLOSAMIDE [IP/BP] NICLOSAMIDE [IP/BP]
S-AMLODIPINE S-AMLODIPINE
AMLODIPINE BASE & PTHALOYAL AMLODIPINE MALIATE
INTERMEDIATES
AMLODIPINE PTHALOYAL AMLODIPINE PTHALOYAL
AMLODIPINE BASE AMLODIPINE BASE
SULPHONAMIDE OF GLIBENCLAMIDE SULPHONAMIDE OF GLIBENCLAMIDE
HYDROXY ETHYL PHTHLAMIDE HYDROXY ETHYL PHTHLAMIDE
METHYL 3-AMINO CROTONATE METHYL 3-AMINO CROTONATE

UNDER DEVELOPMENT
PREGABALINE
PREGABALINE
BROMHEXINE HCL
BROMHEXINE HCL


  • DMF OPEN PART IN CTD FORMATE  AVAILABLE ON REQUEST FOR AMLODIPINE BESILATE & GLIBENCLAMIDE.


and their advance Intermediaries. Since its inception, we have been the sole and reliable manufacturer and exporter of bulk drugs and intermediates. We manufacture our own brands as well as under neutral labels as required by the buyers. Catering as per customers requirements is our specialization. Our quality bulkdrugs & intermediates are exported worldwide.

We are specializes in the development of new processes, which can be designed to ensure the non-infringement of patents, through the application of alternative synthetic procedures. Manufacture of patent free products to the manufacture of novel products through bilateral agreement between ourselves and our clients.


We serve quality drugs on

Regarding Bulk Drugs & intermediates, our service is one of the best as we specialize in collecting various bulk drugs & intermediates required for a factory and ship them together. The whole process is completely reliable and does not require any follow up by the buyers. We can supply from 1 kg to huge quantities as ordered by the buyers. If required on emergency basis, supplies can be made by air within 1 week from the confirmation in the routine conditions.